A novel coronavirus infection COVID-19 in practice of obstetrician-gynecologist: a review of current data and guidelines
https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.142
Abstract
In December 2019, a new type of coronavirus was identified in China, called SARS-CoV-2 (COVID-19) that quickly spread not only within the People’s Republic of China, but also far beyond its borders. On March 11, 2020, the World Health Organization announced that the infection caused by novel coronavirus SARS-CoV-2 became a pandemic. Prior to this, two global epidemics were caused by pathogenic coronaviruses: in 2002 – by SARS-CoV that caused severe acute respiratory syndrome (SARS), and in 2012 – by MERSCoV that resulted in the Middle East respiratory syndrome (MERS). All coronavirus infections in humans are characterized by damage of lower respiratory tract with development of severe pneumonia and respiratory distress syndrome. According to reports, males become sick more often than females. It is known that due to developing immunological suppression pregnant women are at higher risk of contracting infectious diseases. However, the clinical course of SARS-CoV-2 infection during pregnancy, its effect on outcome of gestation, and the likelihood of vertical transmission to the fetus still remain unanswered. In this review, we present data on cases of SARS-CoV-2 disease during pregnancy published globally, its effect on outcome of gestation, as well as data on potential routes of infection for fetus and neonates. In addition, we also provide currently available clinical recommendations released by the Royal Society of Obstetricians and Gynecologists (UK), the American Society of Obstetricians and Gynecologists (USA), and the National Institute for Reproductive Health Research (India) on the management of pregnant patients infected with SARS-CoV-2.
About the Authors
E. Yu. IupatovRussian Federation
Evgenii Yu. Iupatov – MD, PhD, Associate Professor, Head of Department of Obstetrics and Gynecology
36 Butlerova Str., Kazan 420015
Scopus Author ID: 57201192778
L. I. Maltseva
Russian Federation
Larisa I. Maltseva – MD, Dr Sci Med, Professor, Department of Obstetrics and Gynecology
36 Butlerova Str., Kazan 420015
R. S. Zamaleeva
Russian Federation
Roza S. Zamaleeva – MD, Dr Sci Med, Professor, Department of Obstetrics and Gynecology
36 Butlerova Str., Kazan 420015
T. P. Zefirova
Russian Federation
Tatyana P. Zefirova – MD, Dr Sci Med, Professor, Department of Obstetrics and Gynecology
36 Butlerova Str., Kazan 420015
O. V. Chechulina
Russian Federation
Olga V. Chechulina – MD, Dr Sci Med, Professor, Department of Obstetrics and Gynecology
36 Butlerova Str., Kazan 420015
M. I. Mazitova
Russian Federation
Madina I. Mazitova – MD, Dr Sci Med, Professor, Department of Obstetrics and Gynecology
36 Butlerova Str., Kazan 420015
T. E. Kurmanbaev
Russian Federation
Timur E. Kurmanbaev – MD, PhD, Faculty Member, Department of Obstetrics and Gynecology
6 Klinicheskaya Str., Saint Petersburg 194044
References
1. Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181–92. DOI: 10.1038/s41579-018-0118-9.
2. Schwartz D.A., Graham A.L. Potential maternal and infant outcomes from coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020;12(2). pii: E194. DOI: 10.3390/v12020194.
3. Hui D.S.C., Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin N Am. 2019;33(4):869–89. DOI: 10.1016/j.idc.2019.07.001.
4. Zheng F., Tang W., Li H. et al. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha. Eur Rev Med Pharmacol Sci. 2020;24(6):3404–10. DOI: 10.26355/eurrev_202003_20711.
5. Lou J., Tian S.-J., Niu S.-M. et al. Coronavirus disease 2019: a bibliometric analysis and review. Eur Rev Med Pharmacol Sci. 2020;24(6):3411–21. DOI: 10.26355/eurrev_202003_20712.
6. Rasmussen S.A., Smulian J.C., Lednicky J.A. et al. Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020 Feb 24. pii: S0002-9378(20)30197-6. DOI: 10.1016/j.ajog.2020.02.017.
7. Li T., Lu H., Zhang W. Clinical observation and management of COVID19 patients. Emerg Microbes Infect. 2020;9(1):687–90. DOI: 10.1080/22221751.2020.1741327.
8. Li Y., Wu W., Yang T. et al. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19. Zhonghua Nei Ke Za Zhi. 2020;59(0):E003. DOI: 3760.10/cma.j.cn112138-20200221-00114. [Epub ahead of print].
9. Liu H., Liu F., Li J. et al. Clinical and CT imaging features of the COVID19 pneumonia: focus on pregnant women and children. J Infect. 2020;80(5):e7–e13. DOI: 10.1016/j.jinf.2020.03.007.
10. Ai T., Yang Z., Hou H. et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. Feb 26 2020. DOI: 10.1148/radiol.2020200642.
11. Chen H., Guo J., Wang C. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):P809–15. DOI: 10.1016/S0140-6736(20)30360-3.
12. Liu W., Wang Q., Zhang Q. et al. Coronavirus disease 2019 (COVID-19) during pregnancy: A case series. Virology Articles. Preprints 2020;2020020373. Available at: https://www.preprints.org/manuscript/202002.0373/v1. [Accessed: 30.04.2020].
13. Zhu H., Wang L., Fang C. et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9(1):51–60. DOI: 10.21037/tp.2020.02.06.
14. Wang X., Zhou Z., Zhang J. et al. A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery. Clin Infect Dis. 2020 Feb 28. pii: ciaa200. DOI: 10.1093/cid/ciaa200. [Epub ahead of print].
15. Lu Z., Yan J., Min W. et al. Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province. Zhonghua Fu Chan Ke Za Zhi. 2020;55(0):E009. DOI: 10.3760/cma.j.cn112141-20200218-00111. [Epub ahead of print].
16. Iqbal S.N., Overcash R., Mokhtari N. et al. An uncomplicated delivery in a patient with Covid-19 in the United States. N Engl J Med. 2020;382(16):e34. DOI: 10.1056/NEJMc2007605.
17. Karami P., Naghavi M., Feyzi A. et al. Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings. Travel Med Infect Dis. 2020 Apr 11:101665. DOI:10.1016/j.tmaid.2020.101665. [Epub ahead of print].
18. Sutton D., Fuchs K., D’Alton M., Goffman D. Universal screening for SARS-CoV-2 in women admitted for delivery. N Engl J Med. 2020 Apr 13. DOI: 10.1056/NEJMc2009316. [Epub ahead of print].
19. Schwartz D.A. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020 Mar 17. DOI: 10.5858/arpa.2020-0901-SA. [Epub ahead of print].
20. Coronavirus (COVID-19) infection in pregnancy. Royal College of Obstetricians and Gynaecologists: London, 2020. 61 p. Available at: https://www.rcog.org.uk/globalassets/documents/guidelines/2020-04-17-coronavirus-covid-19-infection-in-pregnancy.pdf. [Accessed: 30.04.2020].
21. Report of the WHO-China joint mission on Coronavirus disease-2019 (COVID-19). World Health Organization. 16-24 February 2020. 40 p. Available at: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. [Accessed: 30.04.2020].
22. Khan S., Jun L., Siddique R.N.et al. Association of COVID-19 infection with pregnancy outcomes in healthcare workers and general women. Clin Microbiol Infect. April 08, 2020. DOI: 10.1016/j.cmi.2020.03.034. [In press].
23. El-Gilany A.H. COVID-19 and breastfeeding. Asp Biomed Clin Case Rep. 2020;3(2):102–5. DOI: 10.36502/2020/ASJBCCR.6194.
24. Dong L., Tian J., He S. et al. Possible vertical transmission of SARSCoV-2 from an infected mother to her newborn. JAMA. 2020 Mar 26. DOI: 10.1001/jama.2020.4621. [Epub ahead of print].
25. Guidance for management of pregnant women in COVID-19 pandemic. ICMR–National Institute for Research in Reproductive Health, 2020. 17 p. Available at: http://www.nirrh.res.in/wp-content/uploads/2020/04/Guidance-for-Management-of-Pregnant-Women-in-COVID-19-Pandemic.pdf. [Accessed: 30.04.2020].
26. Outpatient assessment and management for pregnant women with suspected or confirmed novel coronavirus (COVID-19). American College of Obstetricians and Gynecologists, 2020. 1 p. Available at: https://www.uab.edu/medicine/obgyn/images/COVID-19/COVID-19-Algorithm5.pdf. [Accessed: 30.04.2020].
27. [Organizaciya okazaniya medicinskoj pomoshchi beremennym, rozhenicam, rodil'nicam i novorozhdennym pri novoj koronavirusnoj infekcii COVID-19. Metodicheskie rekomendacii. Versiya 1 (24.04.2020)]. Ministerstvo zdravoohraneniya Rossijskoj Federacii, 2020. 61 s. Available at: https://static-1.rosminzdrav.ru/system/attachments/attaches/000/050/093/original/23042020_Preg_COVID19_1_Final.pdf. [Accessed: 30.04.2020].
Review
For citations:
Iupatov E.Yu., Maltseva L.I., Zamaleeva R.S., Zefirova T.P., Chechulina O.V., Mazitova M.I., Kurmanbaev T.E. A novel coronavirus infection COVID-19 in practice of obstetrician-gynecologist: a review of current data and guidelines. Obstetrics, Gynecology and Reproduction. 2020;14(2):148-158. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.142

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.